News

Popular injected weight loss medications work better for one sex. Researchers want to know why
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Novo Nordisk CEO's surprise exit after setbacks in weight-loss market: Reaction
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
Is Zepbound or Wegovy better for weight loss? First-of-its-kind study offers answer
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
Rolling Out9h
Why weight loss giant Novo Nordisk dumped its CEO
The company behind the weight loss sensation that transformed bodies and bank accounts across America just showed its own CEO ...
Novo Nordisk CEO's Surprise Exit After Setbacks in Weight-Loss Market
"The Novo Nordisk Foundation is increasing its influence and has appointed its chairman, Lars Rebien Sørensen, as an observer ...
Everyday Health on MSN2d
Zepbound Beats Wegovy for Weight Loss in First Head-to-Head Trial
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
inews.co.uk on MSN12h
Why it’s getting easier to get a weight-loss jab on the NHS
First results from NHS patients getting Wegovy through an app show treatment via smartphone works as well as in-person ...